Department of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy.
Department of Clinical Sciences and Community Health, University of Milano, Italy.
Semin Thromb Hemost. 2015 Apr;41(3):287-93. doi: 10.1055/s-0035-1549092. Epub 2015 Apr 3.
D-dimer is the biochemical gold standard for diagnosing a variety of thrombotic disorders, but result reporting is heterogeneous in clinical laboratories. A specific five-item questionnaire was developed to gain a clear picture of the current standardization of D-dimer test results. The questionnaire was opened online (December 24, 2014-February 10, 2015) on the platform "Google Drive (Google Inc., Mountain View; CA)," and widely disseminated worldwide by newsletters and alerts. A total of 409 responses were obtained during the period of data capture, the largest of which were from Italy (136; 33%), Australia (55; 22%), Croatia (29; 7%), Serbia (26; 6%), and the United States (21; 5%). Most respondents belonged to laboratories in general hospitals (208; 51%), followed by laboratories in university hospitals (104; 26%), and the private sector (94; 23%). The majority of respondents (i.e., 246; 60%) indicated the use of fibrinogen equivalent unit for expressing D-dimer results, with significant heterogeneities across countries and health care settings. The highest prevalence of laboratories indicated they were using "ng/mL" (139; 34%), followed by "mg/L" (136; 33%), and "µg/L" (73; 18%), with significant heterogeneity across countries but not among different health care settings. Expectedly, the vast majority of laboratories (379; 93%) declared to be using a fixed cutoff rather than an age-adjusted threshold, with no significant heterogeneity across countries and health care settings. The results of this survey attest that at least 28 different combinations of measurement units are currently used to report D-dimer results worldwide, and this evidence underscores the urgent need for more effective international joined efforts aimed to promote a worldwide standardization of D-dimer results reporting.
D-二聚体是诊断各种血栓性疾病的生化金标准,但临床实验室的结果报告存在异质性。我们开发了一个特定的五项目问卷,以清楚地了解当前 D-二聚体检测结果的标准化情况。该问卷于 2014 年 12 月 24 日至 2015 年 2 月 10 日在“Google 云端硬盘(Google Inc.,山景;CA)”平台上在线开放,并通过新闻稿和提醒在全球范围内广泛传播。在数据采集期间共获得了 409 份回复,其中数量最多的来自意大利(136;33%)、澳大利亚(55;22%)、克罗地亚(29;7%)、塞尔维亚(26;6%)和美国(21;5%)。大多数回复者来自综合医院的实验室(208;51%),其次是大学医院的实验室(104;26%)和私营部门(94;23%)。大多数回复者(即 246;60%)表示使用纤维蛋白原当量单位表示 D-二聚体结果,各国和不同医疗保健环境之间存在显著差异。使用“ng/mL”的实验室比例最高(139;34%),其次是“mg/L”(136;33%)和“µg/L”(73;18%),各国之间存在显著差异,但不同医疗保健环境之间没有差异。不出所料,绝大多数实验室(379;93%)表示正在使用固定截止值而不是年龄调整阈值,各国和不同医疗保健环境之间没有显著差异。这项调查的结果表明,目前全球至少有 28 种不同的测量单位组合用于报告 D-二聚体结果,这一证据突显了迫切需要更有效的国际联合努力,以促进全球 D-二聚体结果报告的标准化。